Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

Clinical trial NCT07117877 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07117877
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum Resistant Ovarian Cancer Platinum Refractory Epithelial Ovarian Cancer Ovarian Cancer (OvCa)

Start date: 2025-09-15
Primary completion: 2026-08-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.